Aldosterone: A mediator of myocardial necrosis and renal arteriopathy

Endocrinology

Volumn 141, Issue 10, 2000, Pages 3871-3878

  Rocha, Ricardo ^a   Stier Jr , Charles T ^b   Kifor, Imre ^a   Ochoa Maya, Margarita R ^a   Rennke, Helmut G ^a   Williams, Gordon H ^a   Adler, Gail K ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ANGIOTENSIN; EPLERENONE; N(G) NITROARGININE METHYL ESTER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; BLOOD VESSEL INJURY; CONTROLLED STUDY; HEART INJURY; HEART MUSCLE NECROSIS; HYPERTENSION; KIDNEY DISEASE; KIDNEY INJURY; KIDNEY NECROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEINURIA; RAT; SYSTOLIC BLOOD PRESSURE;

EID: 0033745021     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.141.10.7711     Document Type: Article

References (39)

1. Essential hypertension: Renin and aldosterone, heart attack and stroke
2. Association of the renin-sodium profile with the risk of myocardial infarction in patients with hypertension
3. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure
4. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: Results of the Survival and Ventricular Enlargement Trial
5. Randomized trial of losartan versus captopril in patients over 65 with heart failure. (Evaluation of Losartan in the Elderly Study, ELITE)
6. Influence of the angiotensin II antagonist valsartan on left ventricular hypertrophy in patients with essential hypertension
7. Enalapril prevents stroke and kidney dysfunction in salt-loaded stroke-prone spontaneously hypertensive rats
8. Therapeutic benefit of captopril in salt-loaded stroke-prone spontaneously hypertensive rats is independent of hypotensive effect
9. Therapeutic advantages of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat
10. Control of blood pressure and end-organ damage in maturing salt-loaded stroke-prone spontaneously hypertensive rats by oral angiotensin II receptor blockade
11. Stroke prevention by losartan in stroke-prone spontaneously hypertensive rats
12. Coronary vascular remodeling and myocardial fibrosis in the rat with renovascular hypertension: Response to captopril
13. The renin-angiotensin-aldosterone system in hypertensive disorders: A key to two forms of arteriolar constriction and a possible clue to risk of vascular injury (heart attack and stroke) and prognosis
14. Changes in left ventricular anatomy and function in hypertension and primary aldosteronism
15. Albuminuria in untreated patients with primary aldosteronism or essential hypertension
16. Vascular complications in patients with aldosterone producing adenoma in Japan: Comparative study with essential hypertension
17. Cardiovascular complications in patients with primary aldosteronism
18. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators
19. Mineralocorticoid blockade reduces vascular injury in stroke-prone hypertensive rats
20. Role of aldosterone in renal vascular injury in stroke-prone hypertensive rats
21. The role of blood pressure and aldosterone in the production of hemorrhagic stroke in captopril-treated hypertensive rats
22. Role of aldosterone in the remnant kidney model in the rat
23. Myocardial fibrosis: Role of angiotensin II and aldosterone
24. Determinants of cardiac fibrosis in experimental hypermineralocorticoid states
25. Collagen metabolism in cultured adult rat cardiac fibroblasts: Response to angiotensin II and aldosterone
26. Aldosterone and cardiac fibrosis: In vitro studies
27. Chronic inhibition of nitric oxide synthesis. A new model of arterial hypertension
28. Angiotensin II-induced cardiac fibrosis in the rat is increased by chronic inhibition of nitric oxide synthase
29. Antimineralocorticoid activity of three novel aldosterone antagonists in the conscious dog and in man
30. Eplerenone (SC 66110), a highly selective aldosterone antagonist
31. Effects of adrenalectomy and chronic adrenal corticosteroid replacement on potassium transport in rat kidney
32. Vascular aldosterone in genetically hypertensive rats
33. Prerequisite for cardiac aldosterone action. Mineralocorticoid receptor and 11β-hydroxysteroid dehydrogenase in the human heart
34. Angiotensin AT1 receptor subtype as a cardiac target of aldosterone: Role in aldosterone-salt-induced fibrosis
35. Potentiation of angiotensin II action by corticosteroids in vascular tissue
36. Aldosterone reverses the protective effects of adrenalectomy against endorgan damage in stroke-prone spontaneously hypertensive rats
37. Role of mineralocorticoids in renal injury in stroke-prone hypertensive rats
38. Adrenalectomy ameliorates ablative nephropathy in the rat independently of corticosterone maintenance level
39. Early induction of transforming growth factor-β via angiotensin II type 1 receptors contributes to cardiac fibrosis induced by long-term blockade of nitric oxide synthesis in rats